Tania-Mihaela N.
- Country
- Sweden
- Department
- Department of oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 30 partner sites.
Specializations
Melanoma Research
This investigator specializes in the study of cutaneous malignant melanoma, with particular focus on advanced stages of the disease. Their research encompasses treatment approaches for patients with stage IIb-c, III and IV melanoma.
- High-risk melanoma management
- Post-surgical treatment protocols
- Adjuvant therapy optimization
The investigator's expertise extends to exploring innovative approaches in immunotherapy treatments following radical surgery.
Immunotherapy Focus
The investigator demonstrates particular interest in adjuvant immunotherapy applications, specifically examining treatment duration optimization for melanoma patients after surgical intervention.
- Treatment duration assessment
- Post-operative immunotherapy
- Clinical outcomes evaluation
Their work contributes to understanding the effectiveness of different immunotherapy treatment durations in the adjuvant setting.
Surgical Oncology
The investigator's research encompasses radical surgery approaches for melanoma treatment, particularly focusing on high-risk cases requiring additional therapeutic intervention.
- Post-surgical care protocols
- High-risk patient management
- Treatment sequence optimization
Their work involves integrating surgical interventions with subsequent immunotherapy treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.